2,541–2,560 of 6,563Income metrics use the latest annual filing · balance metrics use the latest reported period
CompanyMarket capP/ERevenueRev. growthNet incomeCashDebtAI value
NWBONorthwest Biotherapeutics Inc$289.28M$1.38M-0.3%-$60.16M$595K$51.97MAI pending
JWSMFJaws Mustang Acquisition Corp$289.5M$271.21KAI pending
BPRNPrinceton Bancorp, Inc.$289.56M11.2×$84.28M+12.8%$18.61M$66.19M$0AI pending
KPETKPET Ultra Paceline Corp$289.85M$1.37MAI pending
EGHT8x8 Inc$290.32M60.4×$735.75M+2.9%$1.65M$90.6M$307.35MAI pending
ESCAEscalade Inc$290.33M12.7×$240.16M-4.5%$13.7M$16.39M$14.88MAI pending
ADACAmerican Drive Acquisition Co$290.37M118.5×$845.2KAI pending
RCMTRcm Technologies, Inc.$290.55M17.8×$319.4M+14.7%$16.33M$6.59MAI pending
AMFNAmerican Fusion, Inc.$290.94M$79.34KAI pending
OVLYOak Valley Bancorp$291M12.3×$81.73M+6.7%$23.91M$194.8MAI pending
ACGCACP Holdings Acquisition Corp.$291M$746.22KAI pending
ANIKAnika Therapeutics, Inc.$291.48M$112.82M-5.9%-$10.88M$38.41M$25MAI pending
JAKKJakks Pacific Inc$291.62M18.3×$570.67M-17.4%$9.87M$59.51M$0AI pending
DBIDesigner Brands Inc.$291.97M30.4×$2.89B-3.9%-$8.37M$50.1M$468.52MAI pending
MTNECH4 Natural Solutions Corp$292.08M$0AI pending
FULCFulcrum Therapeutics, Inc.$292.22M$0-100.0%-$74.88M$48.47MAI pending
PACHPioneer Acquisition I Corp$292.93M36.8×$468.67KAI pending
NHICNewHold Investment Corp. III$293.25M$364KAI pending
IVVDInvivyd, Inc.$293.73M$53.43M+110.5%-$52.49M$160.08MAI pending
IRHOIron Horse Acquisition II Corp.$294.08M115.7×$46.83KAI pending